Top

Reproductive Health

Published in:

Open Access 01-12-2021 | Misoprostol | Commentary

Challenges in the abortion supply chain: a call to action for evaluation research

Authors: Ghazaleh Samandari, Nathalie Kapp, Christopher Hamon, Allison Campbell

Published in: Reproductive Health | Issue 1/2021

Abstract

Background

Reducing the burden of unsafe abortion rests considerably on women’s ability to access appropriate and timely treatment or services. A critical component of that care relies on a functional supply chain to ensure availability of abortion drugs and supplies within the health system. Disruptions in the supply of medical abortion drugs delay provision of abortion services and can increase the risks to a woman’s health. We examine the ways in which supply chain management (SCM) affects women’s ability to access safe and timely abortion to meet their reproductive health needs and highlight the gap in evaluation research on which SCM interventions best improve access to safe abortion care.

SCM comprises a critical component of efficient and sustainable abortion service provision and is a requisite for expansion of services. Furthermore, governments are responsible for safeguarding links in the abortion supply chain, from registration to distribution of abortion drugs and supplies. Strategic public–private partnerships and use of innovative local or community-based distribution mechanisms can strengthen supply chain systems. Finally, alternatives to the pull-based models of distribution could alleviate bottlenecks in the final steps of abortion supply chains. Programs aimed at increasing access to safe and comprehensive abortion care must include SCM as a foundational component of service provision. Without access to a sustainable and affordable supply of abortion drugs and equipment, any attempt at providing abortion services will be critically limited. More implementation research is needed to identify the most effective interventions for improving SCM.

Sedgh G, Bearak J, Singh S, Bankole A, Popinchalk A, Ganatra B, Rossier C, Gerdts C, Tunçalp Ö, Johnson Jr BR, Johnston HB. Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends. Lancet. 2016;388(10041):258–67. https://doi.org/10.1016/S0140-6736(16)30380-4.

Singh S, Remez L, Sedgh G, Kwok L, Onda T. Worldwide 2017: uneven progress and unequal access. New York: Guttmacher Institute, 2018.

Ganatra B, et al. Global, regional, and subregional classification of abortions by safety, 2010–14: estimates from a Bayesian hierarchical model. Lancet. 2017;390(10110):2346. https://doi.org/10.1016/S0140-6736(17)31794-4.CrossRef

Grimes DA, Benson J, Singh S, Romero M, Ganatra B, Okonofua FE, Shah IH. Unsafe abortion: the preventable pandemic. Lancet. 2006;368(9550):1908–19. https://doi.org/10.1016/S0140-6736(06)69481-6.CrossRefPubMed

Mukasa B, Ali M, Farron M, Van de Weerdt R. Contraception supply chain challenges: a review of evidence from low-and middle-income countries. Eur J Contracept Reprod Health Care. 2017;22(5):384–90.CrossRef

Alkema L, Kantorova V, Menozzi C, et al. National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis. Lancet. 2013;381:1642–52.CrossRef

High Impact Practices in Family Planning (HIP). Supply chain management: investing in contraceptive security and strengthening health systems. Washington, DC: USAID; 2012.

Vledder M, Friedman J, Sjöblom M, et al. Optimal supply chain structure for distributing essential drugs in low income countries: results from a randomized experiment. Ross School of Business Working Paper No. 1269, March 2015.

Sedgh G, Hussain R. Reasons for contraceptive nonuse among women having unmet need for contraception in developing countries. Stud Fam Plan. 2014;45:151–69.CrossRef

10.

Chandani Y, Andersson S, Heaton A, et al. Making products available among community health workers: evidence for improving community health supply chains from Ethiopia, Malawi, and Rwanda. J Glob Health. 2014;4:020405. https://doi.org/10.7189/jogh.04.020405.CrossRefPubMedPubMedCentral

11.

Daff BM, Seck C, Belkhayat H, et al. Informed push distribution of contraceptives in Senegal reduces stockouts and improves quality of family planning services. Glob Health Sci Pract. 2014;2:245–52.CrossRef

12.

Shieshia M, Noel M, Andersson S, et al. Strengthening community health supply chain performance through an integrated approach: using mHealth technology and multilevel teams in Malawi. J Glob Health. 2014;4:020406. https://doi.org/10.7189/jogh.04.020406.CrossRefPubMedPubMedCentral

13.

Polus S, Lewin S, Glenton C, et al. Optimizing the delivery of contraceptives in low- and middle-income countries through task shifting: a systematic review of effectiveness and safety. Reprod Health. 2015;12:27. https://doi.org/10.1186/s12978-015-0002-2.CrossRefPubMedPubMedCentral

14.

Cook S, de Kok B, Odland ML. ‘It’s a very complicated issue here’: understanding the limited and declining use of manual vacuum aspiration for postabortion care in Malawi: a qualitative study. Health Pol Plan. 2017;32(3):305–13. https://doi.org/10.1093/heapol/czw128.CrossRef

15.

Tumasang F, Leke RJ, Aguh V. Expanding the use of manual vacuum aspiration for incomplete abortion in selected health institutions in Yaoundé, Cameroon. Int J Gynaecol Obstet. 2014;126:S28-30. https://doi.org/10.1016/j.ijgo.2014.03.014.CrossRefPubMed

16.

Graff M, Amoyaw DA. Barriers to sustainable MVA supply in Ghana: challenges for the low-volume, low-income providers. Afr J Reprod Health. 2009. https://doi.org/10.1186/1472-6963-14-28.CrossRefPubMed

17.

Ji N, Zhou Y, Zhang Y, He D, Pang C, Xi M, Cheng Y. Medical abortion service in rural areas of Henan Province, China: a provider survey. J Obstet Gynaecol Res. 2013;39(3):672–9. https://doi.org/10.1111/j.1447-0756.2012.02004.x.CrossRefPubMed

18.

Ngo TD, Free C, Le HT, Edwards P, Pham KH, Nguyen YB, Nguyen TH. Knowledge and provision practices regarding medical abortion among public providers in Hanoi, Khanh Hoa, and Ho Chi Minh City, Vietnam. Int J Gynaecol Obstet. 2014;124(3):216–21. https://doi.org/10.1016/j.ijgo.2013.08.015.CrossRefPubMed

19.

Johnson BR Jr, Maksutova E, Boobekova A, Davletova A, Kazakbaeva C, Kondrateva Y, Landoulsi S, Lazdane G, Monolbaev K, Jo AH. Provision of medical abortion by midlevel healthcare providers in Kyrgyzstan: testing an intervention to expand safe abortion services to underserved rural and periurban areas. Contraception. 2018;97(2):160–6. https://doi.org/10.1016/j.contraception.2017.11.002.CrossRefPubMed

20.

Kestler E, Valencia L, Del Valle V, Silva A. Scaling up post-abortion care in Guatemala: initial successes at national level. Reprod Health Matters. 2006;14(27):138–47. https://doi.org/10.1016/S0968-8080(06)27235-5.CrossRefPubMed

21.

Atukunda EC, Brhlikova P, Agaba AG, Pollock AM. Civil Society Organizations and medicines policy change: a case study of registration, procurement, distribution and use of misoprostol in Uganda. Soc Sci Med. 2015;130:242–9. https://doi.org/10.1016/j.socscimed.2015.02.022.CrossRefPubMed

22.

Coeytaux F, Hessini L, Ejano N, Obbuyi A, Oguttu M, Osur J, Shuken K. Facilitating women’s access to misoprostol through community-based advocacy in Kenya and Tanzania. Int J Gynaecol Obstet. 2014;125(1):53–5. https://doi.org/10.1016/j.ijgo.2013.10.004.CrossRefPubMed

23.

Robinson N, Kapungu C, Carnahan L, Geller S. Recommendations for scale-up of community-based misoprostol distribution programs. Int J Gynaecol Obstet. 2014;125(3):285–8. https://doi.org/10.1016/j.ijgo.2013.12.005.CrossRefPubMed

24.

Ganatra B, Bygdeman M, Bich Thuy P, Duc Vinh N, Manh LV. From research to reality: the challenges of introducing medical abortion into service delivery in Vietnam. Reprod Health Matters. 2004;12(sup24):105–13. https://doi.org/10.2147/IJWH.CrossRefPubMed

25.

Tiruneh GT, et al. Effect of community-based distribution of misoprostol on facility delivery: a scoping review. BMC Pregnancy Childbirth. 2019;19(1):404.CrossRef

Title: Challenges in the abortion supply chain: a call to action for evaluation research
Authors: Ghazaleh Samandari
Nathalie Kapp
Christopher Hamon
Allison Campbell
Publication date: 01-12-2021
Publisher: BioMed Central
Keyword: Misoprostol
Published in: Reproductive Health / Issue 1/2021
Electronic ISSN: 1742-4755
DOI: https://doi.org/10.1186/s12978-020-01060-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Challenges in the abortion supply chain: a call to action for evaluation research

Abstract

Background

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Please log in to get access to this content

Other articles of this Issue 1/2021

Sexual wellbeing in early adolescence: a cross-sectional assessment among girls and boys in urban Indonesia

Perceptions of family, community and religious leaders and acceptability for minimal invasive tissue sampling to identify the cause of death in under-five deaths and stillbirths in North India: a qualitative study

Geographic variation and associated factors of long-acting contraceptive use among reproductive-age women in Ethiopia: a multi-level and spatial analysis of Ethiopian Demographic and Health Survey 2016 data

The missing link between legal age of sexual consent and age of marriage in sub-Saharan Africa: implications for sexual and reproductive health and rights

Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives

Social contexts of fertility desire among non-childbearing young men and women aged 15–24 years in Nigeria